MX9703839A - Soluciones intravenosas de lubeluzol. - Google Patents

Soluciones intravenosas de lubeluzol.

Info

Publication number
MX9703839A
MX9703839A MX9703839A MX9703839A MX9703839A MX 9703839 A MX9703839 A MX 9703839A MX 9703839 A MX9703839 A MX 9703839A MX 9703839 A MX9703839 A MX 9703839A MX 9703839 A MX9703839 A MX 9703839A
Authority
MX
Mexico
Prior art keywords
lubeluzole
intravenous solutions
solution
intravenous
preparing
Prior art date
Application number
MX9703839A
Other languages
English (en)
Other versions
MXPA97003839A (es
Inventor
Marc Karel Josef Francois
Josef Peeters
Christiane Gabriella Gerardus
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of MXPA97003839A publication Critical patent/MXPA97003839A/es
Publication of MX9703839A publication Critical patent/MX9703839A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describe una solucion para administracion intravenosa que contiene lubelozol o una sal de adicion farmacéuticamente aceptable del mismo, un agente isotonizador, agua y substancias ácidas y básicas para ajustar el pH de la solucion en la escala de 2.5 a 3.6; así como procedimientos para preparar la misma.
MX9703839A 1994-11-24 1995-11-16 Soluciones intravenosas de lubeluzol. MX9703839A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94203422 1994-11-24
EP94203422.4 1994-11-24
PCT/EP1995/004520 WO1996015790A1 (en) 1994-11-24 1995-11-16 Lubeluzole intravenous solutions

Publications (2)

Publication Number Publication Date
MXPA97003839A MXPA97003839A (es) 1997-08-01
MX9703839A true MX9703839A (es) 1997-08-30

Family

ID=8217408

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9703839A MX9703839A (es) 1994-11-24 1995-11-16 Soluciones intravenosas de lubeluzol.

Country Status (19)

Country Link
US (1) US5744484A (es)
EP (1) EP0794777A1 (es)
JP (1) JPH10509712A (es)
CN (1) CN1166787A (es)
AR (1) AR002001A1 (es)
AU (1) AU693969B2 (es)
BR (1) BR9509821A (es)
CA (1) CA2205606A1 (es)
CZ (1) CZ155897A3 (es)
FI (1) FI972204A0 (es)
HU (1) HUT77390A (es)
IL (1) IL116102A (es)
MX (1) MX9703839A (es)
NO (1) NO972303D0 (es)
PL (1) PL320296A1 (es)
SK (1) SK65197A3 (es)
TR (1) TR199501482A1 (es)
WO (1) WO1996015790A1 (es)
ZA (1) ZA959995B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SA96170106A (ar) * 1995-07-06 2005-12-03 أسترا أكتيبولاج مشتقات حامض أميني جديدة
WO1997015306A1 (en) * 1995-10-25 1997-05-01 Janssen Pharmaceutica N.V. Infusions of neuroprotectants and perfluorochemicals

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5010198A (en) * 1984-12-03 1991-04-23 Janssen Pharmaceutica N.V. Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
TR199501482A1 (tr) 1996-10-21
US5744484A (en) 1998-04-28
IL116102A0 (en) 1996-01-31
CN1166787A (zh) 1997-12-03
FI972204A (fi) 1997-05-23
HUT77390A (hu) 1998-04-28
IL116102A (en) 2000-02-29
AU4172996A (en) 1996-06-17
ZA959995B (en) 1997-05-23
BR9509821A (pt) 1997-10-21
JPH10509712A (ja) 1998-09-22
WO1996015790A1 (en) 1996-05-30
CA2205606A1 (en) 1996-05-30
EP0794777A1 (en) 1997-09-17
CZ155897A3 (en) 1997-10-15
NO972303L (no) 1997-05-21
AU693969B2 (en) 1998-07-09
NO972303D0 (no) 1997-05-21
PL320296A1 (en) 1997-09-15
SK65197A3 (en) 1997-12-10
AR002001A1 (es) 1998-01-07
FI972204A0 (fi) 1997-05-23

Similar Documents

Publication Publication Date Title
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
GR3018009T3 (en) Use of gamma-hydroxybutyric acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism, and the compositions obtained.
HUT41418A (en) Process for producing pharmaceutical compositions containing anticoagulator polipeptides and process for producing the active agents
CA2014889A1 (en) Intra-rectal pharmaceutical foam compositions
HU913776D0 (en) Process for the production of heparosane-n,o-sulphates, and medical preparations containing them as active agents
GR3021789T3 (en) 17-Aryl and 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same
HU903094D0 (en) Process for the preparation of antiphlogistic amino-phenol derivatives
HUT41765A (en) Herbicide composition containing 5-amino-1-pyridyl-pyrazole derivatives and process for producing the active agents
HUT55597A (en) Acaricide and insecticide preparation containing halogenized olefines as active agents and process for the production of the active agent
EP0347864A3 (en) Anti-atherogenic agents
GR3002516T3 (en) (s)-(-)-1-propyl-2',6'-pipecoloxylidide hydrochloride monohydrate, process for its preparation and pharmaceutical preparation containing it
HU9202044D0 (en) Method for producing 4-phenyl-piperidine-4-carbixamide derivatives and pharmaceutical preparatives containing these compounds as active agents
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
HU906967D0 (en) Fungicide preparatives containing new amino acid amine derivatives as active substance and process for producing the active substances
HUT46659A (en) Process for producing pyrrolidine-2-(1,3-dicarbonyl) derivatives and pharmaceuticals comprising the same as active ingredient
HUT47096A (en) Process for producing 1,2-dithiol-3-thion derivatives and pharmaceutical compositions containing them as active components
MX9703839A (es) Soluciones intravenosas de lubeluzol.
HU893631D0 (en) Process for producing 1,1-dioxo-cephem-4-carbothiolic acid derivatives and pharmaceutical prepartives containing them as active substance
HUT41965A (en) Insecticide compositions containing s,s-di/terc-alkyl/-thiophosphonate derivatives as active agents and process for producing the active agents
JO1195B1 (en) Pharmaceutical preparations for the treatment of cyanosis and ocular hypertension
AU618896B2 (en) Stable solutions of rebeccamycin analog and preparation thereof
MX9702506A (es) Suspensiones orales de sabeluzol.
HU9202540D0 (en) Method for producing pharmaceutical preparatives containing new 1-benzo-pyrqno(4,3-c)pyrazole derivatives and their active agents
DE69023241D1 (de) Ionophore enthaltende abgabevorrichtung.
HU902110D0 (en) Process for producing 1-phenyl-n-2-chlor-ethyl-carbamoil-7,8-dimethoxy-2,3,4,5-tetrahydro-1h-benzazepine and pharmaceutical preparatives containing these compounds as active agent